Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Hyperpolarized 129Xe MR Lung Imaging in Infants

NCT04995562 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.

NCT NCT04995562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04995562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Hyperpolarized 129Xe MR Lung Imaging in Infants
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Phase
Phase 4
Overall status
Recruiting
Start date
May 6, 2020
Completion date
May 1, 2028
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lungs; developmental disorder